Asymmetric Sulfenylation
FULL PAPER
68.4, 127.0, 127.1, 128.1, 128.7, 128.9, 129.3, 129.8, 136.9, 140.3, 169.7,
199.1; IR (neat): n˜ = 2930, 1714, 1245, 1122, 750, 701 cmÀ1; HRMS: m/z:
calcd for C25H24O3S: 404.1437; found 404.1439 [M]+.
JACHTRENU(G C,F) = d =
28.8 Hz, CF); 19F NMR (188.3 MHz, CDCl3, 258C):
À133.1 ppm (q, J
ACHTRE(UNG F,H) = 3.2 Hz; F); IR (neat): n˜ = 2981, 2932, 1737,
1371, 1258, 1153, 747, 691 cmÀ1; HRMS: m/z: calcd for C14H17FO3S:
284.0877; found 284.0880 [M]+.
Pentafluorobenzyl 2-methyl-3-oxo-2-(phenylsulfanyl)butanoate (3d): The
ee was determined by HPLC using a Daicel Chiralcel AD-H column
2-Methyl-3-oxo-3-phenyl-2-phenylsulfanyl-propanoic acid-tert-amyl ester
(3i): The ee was determined by HPLC using a Daicel Chiralcel AD-H
column (hexane/iPrOH 99:1); flow rate 0.2 mLminÀ1; tmajor = 40 min;
tminor = 36 min); [a]DRT = +104 (c = 0.5 in CH2Cl2, 83% ee); 1H NMR
(hexane/iPrOH 99:1); flow rate 0.6 mLminÀ1; tmajor = 25 min; tminor
=
22 min); [a]RDT
=
À37.0 (c
=
0.50 in CH2Cl2, 74% ee); 1H NMR
(250 MHz, CDCl3, 258C): d = 1.51 (s, 3H; CH3), 2.34 (s, 3H; CH3), 5.27
(s, 2 H, CH2), 7.24–7.44 ppm (m, 5H, Ar-H); 13C NMR (62.9 MHz,
CDCl3, 258C): d = 20.7, 25.8, 54.8, 65.5, 108.4, 129.0, 130.0, 135.5, 136.8,
139.7, 143.7, 147.7, 169.4, 198.9 ppm; 19F NMR (188.3 MHz, CDCl3,
(250 MHz, CDCl3, 258C): d = 0.63 (t, JCAHTRE(UNG H,H) = 7.5 Hz, 3H; CH3), 1.19
(s, 3 H; CH3), 1.30 (s, 3H; CH3), 1.47 (m, 2H; CH2), 1.65 (s, 3H; CH3),
7.24–7.37 (m, 5H; Ar-H), 7.40–7.49 (m, 2H; Ar-H), 7.51–7.59 (m, 1H;
Ar-H), 8.15 ppm (m, 2H; Ar-H); 13C NMR (75.5 MHz, CDCl3, 258C): d
= 7.8, 23.3, 24.4, 24.8, 33.8, 63.9, 86.0, 128.2, 128.8, 129.4, 129.6, 129.7,
132.7, 135.5, 137.3, 170.1, 191.9 ppm; IR (neat): n˜ = 2977, 2933, 1729,
1682, 1370, 1266, 1156, 1129, 1107, 963, 842, 748, 691 cmÀ1; HRMS: m/z:
calcd for C21H24O3S: 356.1441; found 356.1441 [M]+.
258C): d
=
À160.9 (m, 2F), À151.2 (tt, J
ACHTRE(UNG F,H) = 21, 2.2 Hz, 1F),
À141.6 ppm (m, 2F); IR (neat): n˜ = 2936, 1716, 1524, 1508, 1440, 1310,
1233, 1133, 1056, 940, 751, 693 cmÀ1; HRMS: m/z: calcd for C18H13F5O3S:
404.0501; found 404.0504 [M]+.
Benzyl 2-methyl-3-oxo-2-(phenylsulfanyl)butanoate (3e): The ee was de-
termined by HPLC using a Daicel Chiralcel AD-H column (hexane/
iPrOH 99:1); flow rate 0.6 mLminÀ1; tmajor = 39 min; tminor = 31 min);
Ethyl 2-methyl-3-(2-naphthyl)-3-oxo-2-(phenylsulfanyl)propanoate (3j):
The ee was determined by HPLC using a Daicel Chiralcel AS column
[a]RDT
=
À46.0 (c
=
0.50 in CH2Cl2, 63% ee); 1H NMR (250 MHz,
(hexane/iPrOH 99:1); flow rate 0.6 mLminÀ1; tmajor = 19 min; tminor
=
CDCl3, 258C): d = 1.51 (s, 3H; CH3), 2.28 (s, 3H; CH3), 5.22 (s, 2H;
CH2), 7.24–7.43ppm (m, 5H; Ar-H); 13C NMR (75.5 MHz, CDCl3, 258C):
d = 20.7, 26.0, 65.7, 67.9, 128.5, 128.6, 128.9, 129.2, 129.8, 134.8, 136.9,
17 min); [a]RDT
(250 MHz, CDCl3, 258C): d = 0.99 (t, J
(s, 3 H; CH3), 4.13 (dq, J(H,H) = 7.2, 1.1 Hz, 2H; CHH), 7.20–7.41 (m,
5H; Ar-H), 7.58 (m, 2H), 7.88 (d, J(H,H) = 8.5 Hz, 2H; Ar-H), 7.97 (d,
(H,H) = 8.2 Hz, 1H; Ar-H), 8.08 (dd, J(H,H) = 8.7, 1.7 Hz, 1H; Ar-
=
+176 (c
=
0.56 in CH2Cl2, 68% ee); 1H NMR
AHCTREUNG
AHCTREUNG
169.7, 199.2 ppm; IR (neat): n˜ = 2934, 1713, 1234, 1115, 750, 693 cmÀ1
HRMS: m/z: calcd for C18H18O3S: 314.0972; found 314.0971 [M]+.
;
ACHTREUNG
J
C
ACHTREUNG
Phenyl 2-methyl-3-oxo-2-(phenylsulfanyl)pentanoate (3 f): The ee was de-
termined by HPLC using a Daicel Chiralcel AD-H column (hexane/
iPrOH 99:1); flow rate 0.6 mLminÀ1; tmajor = 22 min; tminor = 26 min);
[a]RDT = À25.5 (c = 1 in CH2Cl2, 71% ee); 1H NMR (250 MHz, CDCl3,
1018, 938, 866, 742, 692 cmÀ1
; HRMS: m/z: calcd for C22H20O3S:
258C): d = 1.19 (t, J
(dq, J(H,H) = 17.8 Hz, J
= 17.8 Hz, J
ACHTREUNG(H,H) = 7.2 Hz, 3H; CH3), 1.67 (s, 3H; CH3), 2.76
364.1128; found 364.1133 [M]+.
A
ACHRTUNEG(H,H) = 7.2 Hz, 1H; CHH), 2.98 (dq, JCAHTRE(UGN H,H)
(H,H) = 7.2 Hz, 1H; CHH), 7.08 (m, 2H; Ar-H), 7.22–
1-Ethyl-1-methylpropyl
(250 MHz, CDCl3, 258C): d = 0.83 (t, J
1.28 (d, J(H,H) = 7.2 Hz, 3H; CH3), 1.37 (s, 3H; CH3), 1.80 (m, 4H; 2
2-methyl-3-oxobutanoate
(2k):
1H NMR
7.53 ppm (m, 8H; Ar-H); 13C NMR (62.9 MHz, CDCl3, 258C): d = 8.5,
21.1, 31.7, 65.5, 121.0, 126.3, 129.0, 129.2, 129.6, 130.0, 137.1, 150.4, 168.7,
202.5 ppm; IR (neat): n˜ = 2935, 1754, 1716, 1592, 1493, 1191, 1162, 1086,
ACHTREUNG
AHCTREUNG
CH2), 2.22 (s, 3H; CH3), 3.42 ppm (q,
JACHTRE(UNG H,H) = 7 Hz, 1H; CH);
749, 689 cmÀ1
314.0974 [M]+.
3,5-Di-tert-butylphenyl
(250 MHz, CDCl3, 258C): d = 1.31 (s, 18H; 2CMe3), 1.49 (d, J
7.2 Hz, 3H; CH3), 2.38 (s, 3H; CH3), 3.76 (q, J(H,H) = 7.2 Hz, 1H;
CH), 6.90 (d, J(H,H) 1.5 Hz, 2H; Ar-H), 7.29 ppm (t, J(H,H)
;
HRMS: m/z: calcd for C18H18O3S: 314.0972; found
13C NMR (62.9 MHz, CDCl3, 258C): d = 7.9, 12.8, 22.6, 28.6, 30.3, 30.4,
54.7, 87.1, 169.5, 204.0 ppm; IR (neat): n˜ = 2978, 1715, 1508, 1267, 1134,
849 cmÀ1
.
2-methyl-3-oxobutanoate
(2g):
1H NMR
(H,H) =
A
1,1-Dimethylbutyl 2-methyl-3-oxobutanoate (2l): 1H NMR (250 MHz,
CDCl3, 258C): d = 0.90 (t, J(H,H) = 7.5 Hz, 3H; CH3), 1.24–1.36 (m,
5H; CH2, CH3), 1.43 (s, 6H; 2Me), 1.65–1.75 (m, 2H; CH2), 2.21 (s,
3H; CH3), 3.39ppm (q, J
(H,H) = 7 Hz, 1H; CH); 13C NMR (75.5 MHz,
CDCl3, 258C): d = 12.7, 14.4, 17.1, 25.7, 25.8, 28.4, 43.2, 54.7, 84.1, 169.6,
R
ACHTREUNG
A
=
A
=
1.5 Hz, 1H; Ar-H); 13C NMR (62.9 MHz, CDCl3, 258C): d = 12.8, 28.7,
31.3, 35.0, 53.7, 115.3, 120.1, 150.2, 152.4, 169.2, 203.4 ppm; IR (KBr): n˜
= 2968, 1763, 1709, 1362, 1195, 1144, 1091, 910, 707 cmÀ1; HRMS: m/z:
calcd for C19H28O3: 304.2033; found 304.2036 [M]+.
ACHTREUNG
204.0 ppm; IR (neat): n˜ = 2964, 1716, 1508, 1267, 1147, 846 cmÀ1
1,1,2-Trimethylpropyl 2-methyl-3-oxobutanoate (2m):
(250 MHz, CDCl3, 258C): d = 0.89 (d, J
1.30 (d, J(H,H) = 7 Hz, 3H; CH3), 1.43 (s, 6H; 2CH3), 2.15 (m, 1H;
CH), 2.23 (s, 3H; CH3), 3.42 ppm (q, (H,H) 7 Hz, 1H; CH);
13C NMR (75.5 MHz, CDCl3, 258C): d = 12.7, 17.2, 22.5, 22.7, 28.5, 36.5,
54.8, 87.0, 169.6, 203.9 ppm; IR (neat): n˜ = 2981, 1715, 1136 cmÀ1
1-Ethyl-1-methylpropyl 2-methyl-3-oxo-2-(phenylsulfanyl)butanoate
.
1H NMR
3,5-Di-tert-butylphenyl 2-methyl-3-oxo-2-(phenylsulfanyl)butanoate (3g):
The ee was determined by HPLC using a Daicel Chiralcel OD-H column
ACHTRE(UNG H,H) = 6.8 Hz, 6H; CHMe2),
AHCTREUNG
(hexane/iPrOH 99.7:0.3); flow rate 0.1 mLminÀ1; tmajor = 79 min; tminor
=
J
A
=
72 min); [a]RDT
(250 MHz, CDCl3, 258C): d
=
À34.0 (c
=
0.61 in CH2Cl2, 63% ee); 1H NMR
1.31 (s, 18H; 2CMe3), 1.68 (s, 3H;
(H,H) = 1.3 Hz, 2H; Ar-H), 7.26–7.44
=
.
CH3), 2.52 (s, 3H; CH3), 6.87 (d, JACHTREUNG
(m, 4H; Ar-H), 7.52 ppm (m, 2H; Ar-H); 13C NMR (62.9 MHz, CDCl3,
258C): d = 20.9, 26.3, 31.3, 35.0, 65.9, 114.9, 120.3, 129.1, 129.2, 130.0,
137.0, 150.2, 152.5, 168.6, 199.3 ppm; IR (KBr): n˜ = 2964, 1754, 1719,
(3k): The ee was determined by HPLC using a Daicel Chiralcel OJ
column (hexane/iPrOH 99:1); flow rate 0.6 mLminÀ1; tmajor = 28 min;
1
tminor = 22 min); [a]RDT = À49.5 (c = 0.52 in CH2Cl2, 91% ee); H NMR
1612, 1588, 1226, 1089, 749, 704, 692 cmÀ1
; HRMS: m/z: calcd for
(250 MHz, CDCl3, 258C): d
= 0.88 (t, JACHTRE(GNU H,H) = 7.5 Hz, 6H; 2
C25H32O3S: 412.2067; found 412.2072 [M]+.
CH2CH3), 1.45 (brs, 6H; 2CH3), 1.69–1.99 (m, 4H; 2CH2CH3), 2.41
(s, 3 H; CH3), 7.26–7.45 ppm (m, 5H; Ar-H); 13C NMR (62.9 MHz,
CDCl3, 258C): d = 8.0, 20.8, 22.4, 26.1, 30.3, 30.4, 66.5, 89.1, 128.9, 129.7,
129.7, 136.7, 168.7, 199.3 ppm; IR (neat): n˜ = 2977, 1712, 1254, 1120, 852,
tert-Butyl 2-fluoro-3-oxobutanoate (2h): 1H NMR (250 MHz, CDCl3,
258C): d = 1.51 (s, 9H; CMe3), 2.32 (d, J(H,F) = 3.9 Hz, 3H; CH3),
5.07 ppm (d, J
(H,F) = 49.9 Hz, 1H; CH); 19F NMR (188.3 MHz, CDCl3,
258C): d = À191.6 ppm (qd, J(F,H) = 49.9 Hz, J(F,H) = 3.9 Hz; F).
AHCTREUNG
ACHTREUNG
A
N
748, 693 cmÀ1
308.1439 [M]+.
; HRMS: m/z: calcd for C17H24O3S: 308.1441; found
tert-Butyl 2-fluoro-3-oxo-2-(phenylsulfanyl)butanoate (3h): The ee was
determined by HPLC using a Daicel Chiralcel OJ column (hexane/
iPrOH 99:1); flow rate 0.3 mLminÀ1; tmajor = 66 min; tminor = 59.5 min);
1,1-Dimethylbutyl 2-methyl-3-oxo-2-(phenylsulfanyl)butanoate (3l): The
ee was determined by HPLC using a Daicel Chiralcel AD-H column
[a]RDT
=
À41.0 (c
CDCl3, 258C): d = 1.40 (s, 9H; CMe3), 2.20 (d, J
CH3), 7.30–7.42 (m, 3H; Ar-H), 7.53–7.60 ppm (m, 2H; Ar-H); 13C NMR
(62.9 MHz, CDCl3, 258C): d 26.0, 27.6, 85.3, 105.2 (d, J(C,F)
243.7 Hz, CF), 127.4 (d, J = (C,F) = 1.5 Hz, CF), 129.2, 130.0, 135.7 (d,
(C,F) 1.7 Hz, CF), 162.2 (d, J(C,F) 28 Hz, CF), 196.6 ppm (d,
=
0.545 in CH2Cl2, 90% ee); 1H NMR (250 MHz,
(hexane/iPrOH 99:1); flow rate 0.3 mLminÀ1; tmajor = 22 min; tminor
=
A
24 min); [a]RDT
(250 MHz, CDCl3, 258C): d = 0.92 (t, JAHCTREUNG
=
À62.0 (c
=
0.735 in CH2Cl2, 92.5% ee); 1H NMR
(H,H) = 7.5 Hz, 3H; CH3), 1.25–
=
A
=
1.41 (m, 2H; CH2), 1.45 (s, 3H; CH3), 1.47 (s, 3H; CH3), 1.48 (s, 3H;
CH3), 1.72 (m, 2H; CH2), 2.39 (s, 3H; CH3), 7.27–7.44 ppm (m, 5H; Ar-
H); 13C NMR (62.9 MHz, CDCl3, 258C): d = 14.3, 17.1, 20.6, 25.5, 25.5,
J
A
=
A
=
Chem. Eur. J. 2007, 13, 9384 – 9392
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9389